New pain drug SBS-1000 takes first step in human safety trial
NCT ID NCT05721287
First seen Jan 06, 2026 · Last updated May 22, 2026 · Updated 15 times
Summary
This study tested a single dose of a new experimental drug called SBS-1000 in 48 healthy adults. The main goal was to check for side effects and see how the drug moves through the body. This is an early safety study, so it does not test if the drug actually relieves pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Altasciences Clinical Kansas
Overland Park, Kansas, 66212, United States
Conditions
Explore the condition pages connected to this study.